Gallorini, Simona, Taccone, Marianna, Bonci, Alessandra, Nardelli, Filomena, Casini, Daniele, Bonificio, Amanda, Kommareddy, Sushma, Bertholet, Sylvie, O’Hagan, Derek T., and Baudner, Barbara C.
Subjects
*IMMUNIZATION, *INFLUENZA vaccines, *IMMUNE response, *COMPARATIVE studies, *IMMUNOGLOBULIN A, *T helper cells, *DRUG delivery systems
Abstract
Highlights: [•] This paper provides a novel and original strategy to develop subunit vaccines for sublingual delivery. [•] Sublingual administration of subunit influenza Ags adjuvanted with LTK63 elicited comparable antibody titers to intramuscular immunization. [•] The sublingual delivery elicited Ag-specific mucosal IgA with neutralizing activity, contributing to anti-influenza defenses. [•] The mucosal route in combination with LTK63 elicited an Ag-specific Th17 response that might play a role in protection against influenza. [•] Sublingual delivery of an adjuvanted subunit influenza vaccine could be an effective alternative to conventional intramuscular vaccines. [ABSTRACT FROM AUTHOR]
Abstract: Safe and efficient vaccination is important for rabies prevention in domestic animals. Replicative vectors expressing the rabies virus glycoprotein, derived from canine adenovirus have been reported to be promising vaccines in various animal models. In this paper we compare the potential of a replicative and a non-replicative vector, both based on canine adenovirus type 2 and expressing the rabies glycoprotein. Upon inoculation in sheep, immune responses against the rabies virus protein elicited by recombinant vectors were monitored. All immunised sheep produced a rapid and potent neutralizing antibody response against rabies virus after a single inoculation of either replicative or non-replicative recombinant canine adenovirus type 2. In addition, the non-replicative vector expressing the rabies glycoprotein stimulated antigen-specific CD4+ and CD8+ lymphocyte proliferation as well as IFN-γ production. These results suggest that vectors derived from canine adenovirus 2 could be considered for the development of promising vaccines in the ruminant species. [ABSTRACT FROM AUTHOR]
Stertman, Linda, Strindelius, Lena, and Sjöholm, Ingvar
Subjects
*IMMUNIZATION, *IMMUNE response, *VACCINES, *MICE
Abstract
This paper describes the effects on the development of an immune response by changing the route of administration of a new vaccine adjuvant, starch microparticles with human serum albumin (HSA) as a model antigen. The model vaccine was administered to mice by oral, subcutaneous and intramuscular routes in various combinations and both the local secretory immunoglobulin antibody (s-IgA) and systemic humoral and cellular (delayed-type hypersensitivity assay (DTH)) responses were followed. The only immunisation regimens inducing a significant s-IgA response were those incorporating oral booster doses. Oral and subcutaneous immunisations had similar effects on the Th1/Th2 balance, as indicated by the IgG subclass ratios and cytokine analyses. However, significant differences between oral and intramuscular immunisations were seen in the IgG subclass ratios. The Th2 influence was stronger after oral primary immunisation than after intramuscular primary immunisation, while oral boosters elicited a comparatively stronger Th1 response than intramuscular boosters. This result was also supported by the DTH analyses. Subcutaneous immunisation induced a stronger Th2 response than intramuscular immunisation, as indicated by subclass ratio and the IgE response. In conclusion, our results show that the profile of an immune response depends on the route of administration, which should be considered when developing new vaccines or new routes of administration. [Copyright &y& Elsevier]